These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 34321065)

  • 1. Natural products provide a new perspective for anti-complement treatment of severe COVID-19: a review.
    Fan Y; Wang Y; Yu S; Chang J; Yan Y; Wang Y; Bian Y
    Chin Med; 2021 Jul; 16(1):67. PubMed ID: 34321065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytokine storm associated coagulation complications in COVID-19 patients: Pathogenesis and Management.
    Savla SR; Prabhavalkar KS; Bhatt LK
    Expert Rev Anti Infect Ther; 2021 Nov; 19(11):1397-1413. PubMed ID: 33832398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytokine Storm in COVID-19-Immunopathological Mechanisms, Clinical Considerations, and Therapeutic Approaches: The REPROGRAM Consortium Position Paper.
    Bhaskar S; Sinha A; Banach M; Mittoo S; Weissert R; Kass JS; Rajagopal S; Pai AR; Kutty S
    Front Immunol; 2020; 11():1648. PubMed ID: 32754159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel Coronavirus Disease 2019 (COVID-19) and Cytokine Storms for More Effective Treatments from an Inflammatory Pathophysiology.
    Yokota S; Miyamae T; Kuroiwa Y; Nishioka K
    J Clin Med; 2021 Feb; 10(4):. PubMed ID: 33671159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytokine storm intervention in the early stages of COVID-19 pneumonia.
    Sun X; Wang T; Cai D; Hu Z; Chen J; Liao H; Zhi L; Wei H; Zhang Z; Qiu Y; Wang J; Wang A
    Cytokine Growth Factor Rev; 2020 Jun; 53():38-42. PubMed ID: 32360420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complement-mediated microvascular injury and thrombosis in the pathogenesis of severe COVID-19: A review.
    Gianni P; Goldin M; Ngu S; Zafeiropoulos S; Geropoulos G; Giannis D
    World J Exp Med; 2022 Jul; 12(4):53-67. PubMed ID: 36157337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent updates in the clinical trials of therapeutic monoclonal antibodies targeting cytokine storm for the management of COVID-19.
    Patel S; Saxena B; Mehta P
    Heliyon; 2021 Feb; 7(2):e06158. PubMed ID: 33553708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of Inflammatory Cytokines in COVID-19 Patients: A Review on Molecular Mechanisms, Immune Functions, Immunopathology and Immunomodulatory Drugs to Counter Cytokine Storm.
    Rabaan AA; Al-Ahmed SH; Muhammad J; Khan A; Sule AA; Tirupathi R; Mutair AA; Alhumaid S; Al-Omari A; Dhawan M; Tiwari R; Sharun K; Mohapatra RK; Mitra S; Bilal M; Alyami SA; Emran TB; Moni MA; Dhama K
    Vaccines (Basel); 2021 Apr; 9(5):. PubMed ID: 33946736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calming the inflammatory storm in severe COVID-19 infections: Role of biologics- A narrative review.
    Banji D; Alqahtani SS; Banji OJF; Machanchery S; Shoaib A
    Saudi Pharm J; 2021 Mar; 29(3):213-222. PubMed ID: 33850422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Role of MSC Therapy in Attenuating the Damaging Effects of the Cytokine Storm Induced by COVID-19 on the Heart and Cardiovascular System.
    Ellison-Hughes GM; Colley L; O'Brien KA; Roberts KA; Agbaedeng TA; Ross MD
    Front Cardiovasc Med; 2020; 7():602183. PubMed ID: 33363221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased levels of plasma cytokines and correlations to organ failure and 30-day mortality in critically ill Covid-19 patients.
    Bülow Anderberg S; Luther T; Berglund M; Larsson R; Rubertsson S; Lipcsey M; Larsson A; Frithiof R; Hultström M
    Cytokine; 2021 Feb; 138():155389. PubMed ID: 33348065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coagulopathy as a Prodrome of Cytokine Storm in COVID-19-Infected Patients.
    Guo H; Sheng Y; Li W; Li F; Xie Z; Li J; Zhu Y; Geng J; Liu G; Wang L; Li J; Wang F
    Front Med (Lausanne); 2020; 7():572989. PubMed ID: 33195321
    [No Abstract]   [Full Text] [Related]  

  • 13. Hypoxemia and Cytokine Storm in COVID-19: Clinical Implications.
    Machado C; González-Quevedo A
    MEDICC Rev; 2021; 23(3-4):54-59. PubMed ID: 34516537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tocilizumab in SARS-CoV-2 Patients with the Syndrome of Cytokine Storm: A Narrative Review.
    Kulanthaivel S; Kaliberdenko VB; Balasundaram K; Shterenshis MV; Scarpellini E; Abenavoli L
    Rev Recent Clin Trials; 2021; 16(2):138-145. PubMed ID: 32940187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of Severe COVID-19 with Tocilizumab Mitigates Cytokine Storm and Averts Mechanical Ventilation During Acute Respiratory Distress: A Case Report and Literature Review.
    Farooqi F; Dhawan N; Morgan R; Dinh J; Nedd K; Yatzkan G
    Trop Med Infect Dis; 2020 Jul; 5(3):. PubMed ID: 32635353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytokine storm modulation in COVID-19: a proposed role for vitamin D and DPP-4 inhibitor combination therapy (VIDPP-4i).
    Pinheiro MM; Fabbri A; Infante M
    Immunotherapy; 2021 Jun; 13(9):753-765. PubMed ID: 33906375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complement Activation in Kidneys of Patients With COVID-19.
    Pfister F; Vonbrunn E; Ries T; Jäck HM; Überla K; Lochnit G; Sheriff A; Herrmann M; Büttner-Herold M; Amann K; Daniel C
    Front Immunol; 2020; 11():594849. PubMed ID: 33584662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic Prospects for Th-17 Cell Immune Storm Syndrome and Neurological Symptoms in COVID-19: Thiamine Efficacy and Safety, In-vitro Evidence and Pharmacokinetic Profile.
    Vatsalya V; Li F; Frimodig JC; Gala KS; Srivastava S; Kong M; Ramchandani VA; Feng W; Zhang X; McClain CJ
    medRxiv; 2020 Aug; ():. PubMed ID: 32869036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fighting the storm: could novel anti-TNFα and anti-IL-6
    Kovalchuk A; Wang B; Li D; Rodriguez-Juarez R; Ilnytskyy S; Kovalchuk I; Kovalchuk O
    Aging (Albany NY); 2021 Jan; 13(2):1571-1590. PubMed ID: 33465050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunoregulatory therapy strategies that target cytokine storms in patients with COVID-19 (Review).
    Wang X; He Z; Zhao X
    Exp Ther Med; 2021 Apr; 21(4):319. PubMed ID: 33732292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.